@misc{indiciaece17b7f3fc9a,
  title = {Glyco-engineered pentameric SARS-CoV-2 IgMs show superior activities compared to IgG1 orthologues},
  author = {Kallolimath, S. and Palt, R. and Föderl-Höbenreich, E. and Sun, L. and Chen, Q. and Pruckner, F. and Eidenberger, L. and Strasser, R. and Zatloukal, K. and Steinkellner, H.},
  year = {2022},
  doi = {10.1101/2022.12.22.521646},
  url = {https://www.biorxiv.org/content/10.1101/2022.12.22.521646v1},
  note = {Source identifier: 10.1101/2022.12.22.521646}
}